Clinical Trial Update: Interstitial Lung Disease Trajectories in Patients With Systemic Sclerosis

View source ↗

Summary

Clinical trial update noting that a study evaluating interstitial lung disease trajectories in patients with systemic sclerosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Systemic Sclerosis

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Systemic Sclerosis, Interstitial Lung Disease | Status: RECRUITING